The ICD 10 code for onychomycosis is B35.1, officially described as tinea unguium. Resilient MBS recommends using this code only when the treating provider’s documentation supports a fungal nail infection, rather than selecting it from appearance alone. Thick, discolored, brittle, or separating nails may support the clinical assessment, but the medical record must establish the diagnosis being reported.[1]

For medical billing professionals, finding B35.1 is the easy part. Resilient MBS emphasizes that accurate reimbursement depends on more than entering the diagnosis code. The claim must also reflect the documented condition, service performed, payer coverage criteria, and any additional diagnoses or modifiers required to establish medical necessity.

What Is Onychomycosis?

Onychomycosis is a fungal infection affecting a fingernail or toenail. Resilient MBS uses the term carefully because fungal nail infections can involve dermatophytes, yeasts, or other fungi, while the ICD-10-CM code title for B35.1 is tinea unguium. Toenails are affected more often than fingernails, and common findings may include thickening, discoloration, cracking, brittleness, or separation from the nail bed.[2]

Resilient MBS reminds coding teams that these visible findings are not enough to independently assign a definitive diagnosis. Psoriasis, trauma, nail dystrophy, and other conditions may produce similar changes. Medical billers should code from the provider’s documented assessment and query the appropriate clinical professional when the record is unclear.

What Does B35.1 Include?

The ICD-10-CM tabular classification associates B35.1 with tinea unguium, dermatophytic onychia, dermatophytosis of the nail, onychomycosis, and ringworm of the nails. Resilient MBS therefore treats B35.1 as the primary diagnosis-code answer when a provider clearly documents onychomycosis.[1]

B35.1 does not distinguish between the right and left side, an individual digit, or fingernail versus toenail. Resilient MBS advises billing teams not to add unsupported laterality or anatomical assumptions simply because the claim form or procedure code contains more detail.

How to Use the ICD 10 Code for Onychomycosis Correctly

Correct fungal nail infection coding begins with the clinical record. Resilient MBS recommends confirming that the note identifies the diagnosis, affected nail or nails, relevant symptoms, treatment plan, and reason for any procedure performed.

Code the Confirmed Diagnosis, Not the Suspected Appearance

A note that only states “thickened toenail” may not support B35.1. Resilient MBS would first look for a documented fungal diagnosis or clarification from the provider rather than converting a symptom or nail abnormality into onychomycosis.

Similarly, Resilient MBS advises against replacing B35.1 with a nonspecific nail-disorder code when the provider has clearly documented onychomycosis. The diagnosis submitted should accurately represent the condition established in the medical record.

Use the Code Set Effective for the Date of Service

ICD-10-CM updates follow defined effective dates. Resilient MBS recommends checking the current CMS or NCHS code files instead of relying on old spreadsheets, saved search results, or outdated coding tools. The official browser and annual files contain the tabular instructions needed to validate code use for the relevant date of service.[3]

This date-specific review is especially important when billing teams manage old accounts receivable. Resilient MBS checks the code set applicable to the original service date rather than automatically applying the newest annual version to an older encounter.

Separate Diagnosis Accuracy From Procedure Coverage

B35.1 identifies onychomycosis, but Resilient MBS cautions that the diagnosis code alone does not automatically establish coverage for nail trimming, debridement, surgery, laboratory testing, or another service. Coverage depends on the procedure, payer policy, patient circumstances, and documented medical necessity.

For some Medicare nail-debridement policies, Resilient MBS may need to verify additional documentation involving pain, secondary infection, marked limitation of ambulation, neuropathy, vascular findings, systemic disease, or other qualifying factors. Certain local coverage articles also require a supporting secondary diagnosis or specific modifier.[4]

Documentation That Supports Accurate Onychomycosis Billing

Strong documentation helps Resilient MBS connect the diagnosis, symptoms, treatment, and billed procedure without making assumptions. A concise but complete note may reduce clarification requests, claim rework, and audit exposure.

Document the Condition and Location

Resilient MBS recommends that the record identify whether the condition affects a fingernail or toenail and which nails are involved. Although B35.1 has no laterality, anatomical detail may support the procedure record and demonstrate that the provider evaluated the specific affected area.

The record should also describe clinically relevant findings. Resilient MBS may look for documented thickening, discoloration, brittleness, crumbling, separation, pain, inflammation, infection, or functional limitation when those findings influenced the treatment decision.

Connect Symptoms to the Service Performed

When a procedure is billed, Resilient MBS looks for a clear explanation of why professional treatment was necessary. A diagnosis of onychomycosis may support the condition, but the note should also explain the clinical need for the billed service.

For example, Resilient MBS would expect documentation of pain or impaired ambulation when those facts are being used to satisfy a payer’s nail-debridement coverage policy. Copying the same symptom statement into every encounter without patient-specific support can weaken the record rather than strengthen it.

Record Relevant Testing Without Overstating Requirements

Some providers diagnose fungal nail infections clinically, while testing may be performed when confirmation is needed for treatment or payer purposes. Resilient MBS does not assume that laboratory confirmation is universally required for every B35.1 claim.

Instead, Resilient MBS checks the specific payer policy, service billed, clinical plan, and documentation. If a molecular panel, culture, pathology service, or other test is billed, the record should support why that test was ordered and whether the payer applies separate coverage limitations.

Common Onychomycosis Coding and Billing Mistakes

Even a straightforward code can generate denials when the surrounding claim is incomplete. Resilient MBS encourages billing teams to review these recurring risks before submission:

• Resilient MBS avoids assigning B35.1 when the provider documents only nail thickening or discoloration.

• Resilient MBS does not assume B35.1 alone proves medical necessity for nail debridement.

• Resilient MBS verifies whether a payer requires an additional symptom or systemic-condition code.

• Resilient MBS checks that procedure units match the number of nails treated and documented.

• Resilient MBS validates applicable modifiers against the patient’s findings and payer policy.

• Resilient MBS avoids using old ICD-10-CM lists for current dates of service.

• Resilient MBS reviews local Medicare coverage requirements before treating one jurisdiction’s policy as a nationwide rule.

Real-World Billing Scenario

Consider a podiatry claim reporting B35.1 with a nail-debridement procedure. Resilient MBS reviews the note and finds that the provider documented fungal nails but did not describe pain, secondary infection, ambulation difficulty, qualifying systemic findings, or another payer-required coverage condition.

The diagnosis may be accurate, but Resilient MBS would not assume the procedure is payable. The proper next step is to review the applicable payer policy and existing documentation, then obtain legitimate clarification when appropriate. Changing or adding unsupported diagnoses merely to secure payment would create a compliance problem.

Compliance Considerations for Texas and Virginia Billers

ICD-10-CM diagnosis coding is standardized nationally, so Resilient MBS uses B35.1 for documented onychomycosis in Texas, Virginia, and other U.S. states. However, payment policies for procedures associated with fungal nails may differ by Medicare contractor, Medicaid program, commercial payer, and health plan.

Resilient MBS therefore separates national coding rules from local coverage requirements. Billing professionals should verify the policy that applies to the patient, provider, service date, and jurisdiction rather than assuming that a paid Texas claim guarantees identical coverage in Virginia.

Build an Audit-Ready Process

No billing process can guarantee that a claim will never be reviewed. Resilient MBS instead promotes audit-ready practices built on accurate coding, patient-specific documentation, current payer guidance, secure record handling, and traceable claim corrections.

Resilient MBS also recommends maintaining the source used to support a coding or coverage decision. This may include the current ICD-10-CM tabular list, payer policy, local coverage article, remittance response, and provider clarification.

Why the ICD 10 Code for Onychomycosis Matters

Using B35.1 correctly protects more than one claim. Resilient MBS helps billing teams reduce avoidable denials, prevent unsupported coding, improve documentation feedback, and strengthen revenue-cycle consistency.

As an education-focused resource, Resilient MBS helps medical billing professionals understand the difference between identifying a diagnosis code and proving that a billed service meets coverage requirements. That distinction is essential for accurate, defensible billing.

Medical practices seeking clearer coding workflows can use Resilient MBS resources to review diagnosis selection, documentation gaps, denial patterns, and payer-specific billing requirements. Resilient MBS supports informed decisions without promising guaranteed reimbursement.

FAQs

What Is the ICD 10 Code for Onychomycosis?

Resilient MBS uses B35.1, Tinea unguium, when the provider documents onychomycosis or a fungal nail infection represented by that ICD-10-CM category.

Is B35.1 Used for Both Fingernail and Toenail Fungus?

Yes. Resilient MBS notes that B35.1 does not separately identify fingernails, toenails, laterality, or individual digits. The clinical note should still specify the affected nail or nails.

Can B35.1 Be Assigned From a Thick or Discolored Nail?

Not automatically. Resilient MBS recommends coding the provider’s documented diagnosis because nonfungal conditions can also cause thickening, discoloration, brittleness, or nail separation.

Does B35.1 Alone Support Nail Debridement?

Not always. Resilient MBS verifies the applicable payer policy because some coverage rules require additional symptoms, clinical findings, diagnoses, or modifiers to support medical necessity.

Is the Onychomycosis Code Different in Texas and Virginia?

No. Resilient MBS uses the national ICD-10-CM code B35.1 in both states, but procedure coverage and documentation requirements may vary by payer and jurisdiction.

How Can Billers Reduce Onychomycosis Claim Denials?

Resilient MBS recommends confirming the documented diagnosis, validating the current code set, linking symptoms to the service, checking procedure units and modifiers, and reviewing the applicable payer coverage policy.

Strengthen Fungal Nail Infection Coding With Resilient MBS

The correct ICD 10 code for onychomycosis is only the starting point. Resilient MBS helps billing professionals connect B35.1 with accurate documentation, appropriate procedures, applicable coverage rules, and consistent follow-up.

Explore Resilient MBS educational resources or request a billing review to identify coding gaps, documentation risks, and preventable denial patterns affecting your practice.